Pathogen Detection in Infectious Uveitis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Infectious Panuveitis, Infectious Iridocyclitis. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Pathogen Detection in Infectious Uveitis in China
Overview
Infectious uveitis is a very important blinding disease. Some people who have been diagnosed with idiopathic uveitis may also have the activity of pathogens in the eye. However, due to the limitation of the amount of ocular samples, it is difficult to make a rapid and effective diagnosis of infection.Current study is to explore the infective cause of uveitis in China by using a broad diagnostic approach of detection.
Detailed description
Infectious uveitis is a very important blinding disease. Some people who have been diagnosed with idiopathic uveitis may also have the activity of pathogens in the eye. However, due to the limitation of the amount of ocular samples, it is difficult to make a rapid and effective diagnosis of infection.
The study is to explore the infective cause of uveitis in China by using a broad diagnostic approach of detection, including multiple molecular bio-techniques. We also plan to explore the distribution of pathogens in infectious uveitis.
Primary outcome measures
- Prevalence and distribution of intraocular infections in the study group [Time frame: Oct 2020 to Sep 2022]
Secondary outcome measures (1)
- The sensitivity and specificity of multiple molecular diagnostic methods for detection of bacteria or virus fungi in the study group [Time frame: Oct 2020 to Sep 2022]
Eligibility criteria
Inclusion criteria
- Patient at a referal hospital eye clinic with clinically suspected infectious uveitis
Exclusion criteria
- Patients not eligible for the Inclusion Criteria
- Confirmed auto-immune uveitis
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Xinhua Hospital — Shanghai
Identifiers
NCT: NCT04521673 · XH-20-014